Melinda Gates-supported firm in women's healthcare, Tia, reduces workforce by 23%

Business Insider reports that Tia, a women's health startup, has downsized its workforce by about 23%.

Tailored for women's needs, Tia offers both online and physical health services. The company let go of 27% of its administrative staff (17 individuals), 22% of its healthcare providers (27 individuals), and 23% of its support team (28 individuals), according to an email sent by CEO Felicity Yost.

The layoffs underscore how even high-profile startups with ample funding feel the pinch of the healthcare industry's financial challenges, compounded by venture capitalists' growth demands. Despite its initial backing by Melinda Gates, Tia now faces the test of proving that its model, which merges technology and traditional clinics for women's care, can yield profits.

The failure of similar tech-driven health ventures like Forward, and the struggles faced by major players like Amazon's One Medical, highlights the scaling difficulties in this sector.

In an official comment to Business Insider, Tia confirmed the reduction in their team.

Transformation Facing Tia

Operating as a comprehensive healthcare hub for women, Tia provides everything from gynecological services to mental health support via both in-person and digital platforms. They currently operate 11 clinics, spread across Los Angeles, New York City, San Francisco, and Arizona.

The decision for these layoffs was influenced by recent fundraising feedback, pointing out the company's inability to break even without additional funds, as outlined in Yost's email. The feedback prompted Tia to reevaluate its business strategies amidst a market that demands financial prudence and profitability.

A Tia representative explained that although membership growth surpassed 2025 expectations, the healthcare sector's broad challenges, such as climbing labor costs and narrower reimbursement margins, necessitate greater financial discipline.

Even the best-funded healthcare entities find it tough to maintain physical clinics profitably. For example, Forward abruptly ceased operations after hefty investment rounds, and VillageMD has opted to sell many of its clinics post-separation from Walgreens.

Despite not announcing a funding round since their $100 million Series B in 2021, Tia's internal communications refer to a 'Series C growth strategy.' Tia has not addressed outside queries regarding this round. Additional funding was sourced through Melinda French Gates' Pivotal Ventures in a Series B extension, raising the total funding to $150 million.

Operational Adjustments and Future Plans

Tia emphasizes a push towards operational efficiency and sustainable growth in alignment with industry trends, while maintaining confidence about their high-performance stance. New partnerships and expansion plans are anticipated for the upcoming year.

Challenges like the recent fires in Los Angeles hindered Tia's first-quarter performance, alongside slower business growth than needed, as Yost mentioned.

In response to early-year shortcomings, Tia implemented new strategies: enabling patients access to services without membership, facilitating Tia members' access to GLP-1 prescriptions, and rolling out a national online care offering.

Though the membership-optional service model exceeded objectives, other operational areas performed sub-optimally. Hence, added funding was deemed crucial due to insufficient cash flow to reach profitability.

The additional capital, coupled with feedback, led to the job cuts.

Founded in 2016 by Yost and Carolyn Witte, Tia began with a focus on physical clinics, shifting in 2020 towards a hybrid model during the pandemic.

Leadership Changes and Cost Strategies

Carolyn Witte stepped down from the CEO position in April 2024 to become Tia's chair, with Yost stepping in as interim CEO. The transition followed earlier layoffs in July 2022, which were also attributed to preparing for market volatility.

Yost addressed in her Monday message that alongside job cuts, comprehensive adjustments to spending, including tool and contract expenses, would be enacted. Additionally, senior executive pay would be reduced.

The company can no longer justify hiring clinical staff ahead of demand. Future planning involves optimizing administrative and healthcare roles creatively, ensuring the quality of patient care remains intact.

Personnel impacted by the cuts, especially those directly engaging with patients, lost access to Tia's systems immediately post-announcement.